Clinical Trial Update: Evaluation of Clot Stability Induced by Solulin: Evaluation of New Solulin Mutants Lacking Protein C Activation Capacity

View source ↗

Summary

A completed clinical trial evaluating clot stability induced by Solulin mutants lacking protein C activation capacity in Hemophilia A.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• Solulin

Snippet

Sponsor: University Hospital, Caen | Conditions: Hemophilia A | Status: COMPLETED